Fusetec
Fusetec is an Adelaide-based advanced manufacturing company that 3D prints anatomically accurate, fully operable surgical training models used as an alternative to cadavers.
- CEO / Founder
- Mark Roe
- Team Size
- 11-50
- Stage
- Active
- Latest Round
- Private Equity
- Key Investors
- Proserpine Capital Partners
Technology & Products
Key Products
Anatomically accurate surgical training models across orthopaedic (upper/lower limb), neurology, spine, gynaecology, otolaryngology (sinus, temporal bone), and injectable trainers; also operates the world's first non-cadaveric Advanced Surgical Training Clinic in Adelaide.
Technological Advantage
Proprietary advanced manufacturing process combining 3D printing (Stratasys technology) with custom soft-tissue material science developed over 5+ years of R&D, validated through peer-reviewed publications and surgeon collaborations.
Differentiation
Value Proposition
Provides safe, affordable, repeatable surgical training models that replicate human tissue (including pulsating arteries and controllable bleeding) as an alternative to cadavers, which are expensive, hard to source, and cannot be customized for specific pathologies.
How They Differentiate
Focuses specifically on fully operable, pathology-specific soft-tissue models validated in peer-reviewed clinical studies, plus operates its own physical surgical training clinic rather than only selling models.
Market & Competition
Target Customers
Medical device companies, hospitals, universities, surgical training programs, and individual surgeons/residents worldwide.
Industry Verticals
Medical/Healthcare (surgical education, medtech device training)
Competitors
SynDaver Labs; Simulab Corporation; CAE Healthcare (surgical/medical simulation and synthetic cadaver alternatives)
Growth & Milestones
Major Milestones
2019: FII and AMGC grants with University of SA; 2020: Australian Start-Up of the Year, RDFS Grant with Adelaide University; 2021: Advanced Manufacturer of the Year (Global Healthcare Awards), launched world-first non-cadaveric Advanced Surgical Training Clinic; 2022: Most Innovative Advanced Manufacturing Company, Ausbiotech Emerging Company of the Year; Dec 2025: investment from Proserpine Capital Partners.
Notable Customers
Tier 1 medical device companies (unnamed); surgeons/institutions globally including collaborations with Professor Peter-John Wormald (ENT/sinus surgery).